Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Nicox SA.
  6. News
  7. Summary
    COX   FR0013018124

NICOX SA.

(COX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Number of voting rrights as of November 30, 2021

12/01/2021 | 11:45am EST

Nicox SA

Société anonyme with a registered capital of € 37,138,185

 

Head Office:

DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis 

R.C.S. GRASSE 403.942.642

 

 

On December 1, 2021,

 

 

MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS

 

(Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l’AMF)

 

 

 As of November 30, 2021
Total number of shares composing the share capital37,138,185
Total number of voting rights37,138,185
Total number of voting rights, calculated based on the total number of shares, including the shares deprived of voting rights37,138,185

 

 

---------------

www.nicox.com

Phone: +33 4-97-24-53-00

Fax : +33 4-97-24-53-99

 

Attachment

  • 30 novembre 21 EN

© OMX, source GlobeNewswire - EU Press Releases

All news about NICOX SA.
01/06NICOX : Half-year liquidity contract statement for NICOX
AQ
01/05Nicox Secures European Patent For Allergic Conjunctivitis Treatment
MT
01/05Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
AQ
2021NICOX SA. : Monthly statement on outstanding equity shares and voting rights
CO
2021Nicox Screens First Patient in China in Late-Stage Trial For Glaucoma Treatment
MT
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
AQ
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
CI
2021GLOBAL MARKETS LIVE : General Motors, JP Morgan, Pfizer, Novavax, Ford...
2021Nicox Appoints Novartis Executive as Chief Scientific Officer
MT
2021Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-c..
AQ
More news
Financials
Sales 2021 5,21 M 5,90 M 5,90 M
Net income 2021 -23,5 M -26,6 M -26,6 M
Net cash 2021 19,0 M 21,6 M 21,6 M
P/E ratio 2021 -4,64x
Yield 2021 -
Capitalization 117 M 133 M 133 M
EV / Sales 2021 18,9x
EV / Sales 2022 11,5x
Nbr of Employees 36
Free-Float -
Chart NICOX SA.
Duration : Period :
Nicox SA. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NICOX SA.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 2,72 €
Average target price 11,50 €
Spread / Average Target 323%
EPS Revisions
Managers and Directors
Michele Garufi Chairman & Chief Executive Officer
Sandrine Gestin Vice President-Finance
JosÚ Boyer Head-Research & Development
Doug Hubatsch Chief Scientific Officer
Jean-Franšois LabbÚ Independent Director
Sector and Competitors